• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, May 14, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home Headlines

Elsevier announces the launch of Transplantation Reports

Bioengineer.org by Bioengineer.org
January 30, 2018
in Headlines, Health, Science News
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

New York, February 11, 2016 – Elsevier, a world-leading provider of scientific, technical, and medical information products and services today announces the launch of Transplantation Reports, a new online-only open access journal covering all areas of transplantation. This peer-reviewed journal will contribute to knowledge in clinical and experimental surgery, and will make patient education and history widely available to the transplant community. The journal has begun accepting submissions, and will begin online publication in early 2016.

Barry D. Kahan, PhD, MD is Emeritus Professor and Director Emeritus of the Division of Immunology and Organ Transplantation at The University of Texas Medical School at Houston, where he was Chief of the Organ Transplant Services at The Hermann Hospital for more than 30 years, has been appointed as Editor-in-Chief of this new journal. He also serves as Editor-in-Chief of Transplantation Proceedings.

Dr. Kahan explains that "there is an urgent need for publication of material that is preliminary as well as regional, albeit compelling, related to widely known experiences globally, but not as yet described in a given world region. For example: confirmatory cases, immunosuppression regimens, clinical approaches to problematic situations and outcome reviews".

The journal will publish original research, review articles, editorials, and commentaries related to transplantation. Authors publishing in Transplantation Reports will benefit from rapid review and permanent access to their work on http://www.journals.elsevier.com/transplantation-reports and on ScienceDirect.

Elizabeth Perill, Executive Publisher at Elsevier, commented, "We are extremely pleased to offer this open access journal to our transplantation portfolio as we continue to serve the needs of our communities. We are confident of its success."

###

For more information or to submit an article, visit: http://www.journals.elsevier.com/transplantation-reports.

About open access publishing at Elsevier

Elsevier has been providing open access publishing options since 2005. Today, researchers can choose to publish open access in over 1,600 established peer-reviewed journals as well as over 480 open access journals, and these numbers continue to grow rapidly. All of Elsevier's open access publications have been peer reviewed, ensuring that the broader community not only reads the latest research but that it is factual, original and of the highest quality and ethical standards. For more information about Elsevier's open access program, visit http://www.elsevier.com/openaccess

About Elsevier

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and often make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey — and publishes over 2,500 journals, including The Lancet and Cell, and more than 33,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group plc, a world-leading provider of information solutions for professional customers across industries. http://www.elsevier.com

Media Contact

Elizabeth Perill
[email protected]
212-633-3833
@elseviernews

http://www.elsevier.com

Share12Tweet8Share2ShareShareShare2

Related Posts

SNOR Reactivates Translation After Dormancy — Medicine

SNOR Reactivates Translation After Dormancy

May 14, 2026
Triple-Negative Breast Cancer Ecotypes and Chemotherapy Response — Medicine

Triple-Negative Breast Cancer Ecotypes and Chemotherapy Response

May 14, 2026

Maveropepimut-S Combo Shows Promise in Ovarian Cancer

May 14, 2026

Gaussian Boson Sampling: 1,024 Squeezed States, 8,176 Modes

May 14, 2026
Please login to join discussion

POPULAR NEWS

  • Research Indicates Potential Connection Between Prenatal Medication Exposure and Elevated Autism Risk

    842 shares
    Share 337 Tweet 211
  • New Study Reveals Plants Can Detect the Sound of Rain

    729 shares
    Share 291 Tweet 182
  • Salmonella Haem Blocks Macrophages, Boosts Infection

    62 shares
    Share 25 Tweet 16
  • Breastmilk Balances E. coli and Beneficial Bacteria in Infant Gut Microbiomes

    57 shares
    Share 23 Tweet 14

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

SNOR Reactivates Translation After Dormancy

Triple-Negative Breast Cancer Ecotypes and Chemotherapy Response

Maveropepimut-S Combo Shows Promise in Ovarian Cancer

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 82 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.